ProfileGDS5678 / 1419085_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 39% 32% 38% 36% 37% 43% 54% 41% 37% 38% 38% 36% 42% 38% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.9278639
GSM967853U87-EV human glioblastoma xenograft - Control 22.729132
GSM967854U87-EV human glioblastoma xenograft - Control 32.859838
GSM967855U87-EV human glioblastoma xenograft - Control 42.7696936
GSM967856U87-EV human glioblastoma xenograft - Control 52.8058237
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.1010443
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.4386854
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.9327541
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.8327437
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.8608438
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.8664238
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.7994636
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.9657942
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.8567838